quantisnow
FeedTopReportsPricing
⌘K
Live feed
12:31:48·731d
NEWSRelease
Bio-Path Holdings Inc. logo
GlucoTrack Inc. logo
Hepion Pharmaceuticals Inc. logo
+9

12 Health Care Stocks Moving In Monday's Intraday Session

BPTH· Bio-Path Holdings Inc.GCTK· GlucoTrack Inc.HEPA· Hepion Pharmaceuticals Inc.IKT· Inhibikase Therapeutics Inc.IONM· Assure Holdings Corp.ISPC· iSpecimen Inc.
Health CareTechnology
Original source

Companies

  • BPTH
    Bio-Path Holdings Inc.
    Health Care
  • GCTK
    GlucoTrack Inc.
    Health Care
  • HEPA
    Hepion Pharmaceuticals Inc.
    Health Care
  • IKT
    Inhibikase Therapeutics Inc.
    Health Care
  • IONM
    Assure Holdings Corp.
    Health Care
  • ISPC
    iSpecimen Inc.
    Health Care
  • LIFW
    MSP Recovery Inc.
    Technology
  • NKGN
    NKGen Biotech Inc.
    Health Care
  • OCEA
    Ocean Biomedical Inc.
    Health Care
  • PROK
    ProKidney Corp.
    Health Care
  • TELO
    Telomir Pharmaceuticals Inc.
    Health Care
  • VAXX
    Vaxxinity Inc.
    Health Care

Recent analyst ratings

  • Mar 4IKTUpdateLadenburg Thalmann$4.00
  • Jan 21IKTUpdateBofA Securities$6.00
  • Dec 26IKTUpdateH.C. Wainwright$8.00
  • Dec 16PROKUpdateH.C. Wainwright$12.00
  • Dec 11IKTUpdateCantor Fitzgerald$4.00
  • Jun 30PROKUpdateBofA Securities$1.00

Related

  • SEC1d
    SEC Form D filed by Hepion Pharmaceuticals Inc.
  • SEC1d
    Hepion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
  • PR2d
    Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
  • SEC3d
    SEC Form PRE 14A filed by Inhibikase Therapeutics Inc.
  • SEC6d
    SEC Form DEFA14A filed by ProKidney Corp.
  • SEC6d
    SEC Form DEF 14A filed by ProKidney Corp.
  • SEC9d
    Hepion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
  • SEC9d
    GlucoTrack Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022